Acute reactant cytokines and neutrophil adhesion after warm ischemia in cirrhotic and noncirrhotic human livers

Hepatology

Volumn 23, Issue 6, 1996, Pages 1456-1463

  Clavien, Pierre Alain ^a,b,c   Camargo Jr , Carlos A ^a,b   Gorczynski, Reginald ^a   Washington, Mary K ^b   Levy, Gary A ^a   Langer, Bernard ^a   Greig, Paul D ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b DUKE UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE ADHERENCE; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER ISCHEMIA; LIVER RESECTION; MALE; NEUTROPHIL; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; REPERFUSION INJURY;

EID: 0029952558     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v23.pm0008675164     Document Type: Article

References (15)

1. Clavien P-A, Harvey PRC, Strasberg SM. Preservation and reperfusion injuries in liver allografts: overview and synthesis of current studies. Transplantation 1992;53:957-978.
2. Grace P. Ischaemia-reperfusion injury. Br J Surg 1994;81:637-647.
3. Walker P. Ischemia/reperfusion injury in skeletal muscle. Ann Vasc Surg 1991;5:399-402.
4. Novick R, Menkis A, McKenzie F. New trends in lung preservation: a collective review. J Heart Lung Transplant 1992;11:377-392.
5. Caty M, Guice K, Oldham K, Remick D, Kunkel S. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg 1990;212:694-699.
6. Colletti L, Remick D, Burtch G, Kunkel S, Strieter R, Campbell D Jr. Role of tumor necrosis factor alfa in the pathophysiologic alterations after ischemia/reperfusion injury in the rat. J Clin Invest 1990;85:1936-1943.
7. Chazouilleres O, Guechot J, Balladur P, Masini J-P, Delva E, Laribi A, Giboudeau J, et al. Tumor necrosis factor alpha in liver transplantation and resection: no evidence for a key hole in ischemia-reperfusion injury. J Hepatol 1992;16:376-379.
8. Huguet C, Nordlinger B, Galopin JJ. Normothermic hepatic vascular exclusion for extensive hepatectomy. Surg Gynecol Obstet 1978;147:689-693.
9. Delva E, Camus Y, Nordlinger B, Hannoun L, Parc R, Deriaz H, Lienhart A, et al. Vascular occlusions for liver resections: operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg 1989;209:211-218.
10. Isozaki H, Adam R, Gigou M, Szekely A, Shen M, Bismuth H. Experimental study of the protective effect of intermittent hepatic pedicle clamping in the rat. Br J Surg 1992;79:310-313.
11. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990;192:245-261.
12. Seekamp A, Warren J, Remick D, Till G, Ward P. Requirements for tumor necrosis factor alpha and interleukin-1 in limb ischemia/reperfusion injury and associated lung injury. Am J Pathol 1993;143:453-463.
13. Castell J, Geiger T, Gross V, Andus T, Walter E, Hirano T, Kishimoto T, et al. Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem 1988;177:357-361.
14. Clavien P-A, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 1992;111:518-526.
15. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. HEPATOLOGY 1987;7:660-664.